NOTUM and gastric cancer: For a molecular target to be druggable, with the potential for translation to be the clinic, small-molecule Notum inhibitors as a potential therapeutic for GC have been explored, including LP-922,056, ABC99, Melatonin and Caffeine [21, 49, 50].